SCHEMBL845484

SCHEMBL845484

CCc1ccccc1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ITGB1 P05556 6/20 0.46
ITGA4 P13612 6/20 0.46
PABPC1 P11940 1/20 0.45
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
HCRTR1 O43613 2/20 0.44
HCRTR2 O43614 2/20 0.44
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845205 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL845111 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL1030175 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL13272444 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL845226 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL15116912 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL845415 0.87 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHSD17B10ITGB1
SCHEMBL845473 0.86 HSD17B10 (0.47) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845189 0.86 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845154 0.86 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAHSD17B10ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed